MedTrace Logo

An MRI Study on Muscular Diseases -Pompe Disease and Dystrophia Myotonica-

NCT02708784 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-03-15

No results posted yet for this study

Summary

The aim of the project is to develop new Magnetic Resonance (MR) imaging techniques for better diagnosis and monitoring of patients with muscular disorders.

Muscle quality in patients with Late Onset Pompe Disease (Acid Maltase Deficiency type 2) and in patients with Myotonica Dystrophy will be evaluated, by determining muscle strength in relation to muscle size and muscle strength in relations to fat-muscle ratio.

Conditions

  • Glycogen Storage Disease Type 2
  • Dystrophia Myotonica

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Henning Andersen, Professor · Aarhus University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-08-31
Completion
2016-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02708784 on ClinicalTrials.gov